Question: are nivolumab and pembrolizumab the same?
Answer: Similarly, the approved response rate in urothelial cancer for nivolumab [9] is analogous to that of pembrolizumab, for which approval is pending [10]. Nivolumab is approved as second-line therapy for renal cell carcinoma [11], but there are no comparable data for pembrolizumab as of yet.